| Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test SD Lawn, P Mwaba, M Bates, A Piatek, H Alexander, BJ Marais, ... The Lancet infectious diseases 13 (4), 349-361, 2013 | 627 | 2013 |
| Rapid spread of Zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games E Petersen, ME Wilson, S Touch, B McCloskey, P Mwaba, M Bates, O Dar, ... International Journal of Infectious Diseases 44, 11-15, 2016 | 504 | 2016 |
| Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts BJ Marais, K Lönnroth, SD Lawn, GB Migliori, P Mwaba, P Glaziou, ... The Lancet infectious diseases 13 (5), 436-448, 2013 | 392 | 2013 |
| Drug-resistant tuberculosis: time for visionary political leadership I Abubakar, M Zignol, D Falzon, M Raviglione, L Ditiu, S Masham, I Adetifa, ... The Lancet infectious diseases 13 (6), 529-539, 2013 | 375 | 2013 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 349 | 2022 |
| Tuberculosis: advances and challenges in development of new diagnostics and biomarkers G Walzl, R McNerney, N du Plessis, M Bates, TD McHugh, NN Chegou, ... The Lancet Infectious Diseases 18 (7), e199-e210, 2018 | 348 | 2018 |
| Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities R McNerney, M Maeurer, I Abubakar, B Marais, TD Mchugh, N Ford, ... Journal of Infectious Diseases 205 (suppl_2), S147-S158, 2012 | 279 | 2012 |
| Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies A Zumla, J Chakaya, R Centis, L D'Ambrosio, P Mwaba, M Bates, ... The Lancet Respiratory Medicine 3 (3), 220-234, 2015 | 272 | 2015 |
| Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future N Kapata, C Ihekweazu, F Ntoumi, T Raji, P Chanda-Kapata, P Mwaba, ... International Journal of Infectious Diseases 93, 233-236, 2020 | 263 | 2020 |
| Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects A Zumla, JA Al-Tawfiq, VI Enne, M Kidd, C Drosten, J Breuer, MA Muller, ... The Lancet Infectious Diseases 14 (11), 1123-1135, 2014 | 212 | 2014 |
| Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study M Bates, J O'Grady, M Maeurer, J Tembo, L Chilukutu, C Chabala, ... The Lancet infectious diseases 13 (1), 36-42, 2013 | 212 | 2013 |
| Emergence of new SARS-CoV-2 Variant of Concern Omicron (B. 1.1. 529)-highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine … E Petersen, F Ntoumi, DS Hui, A Abubakar, LD Kramer, C Obiero, ... International Journal of Infectious Diseases 114, 268-272, 2022 | 204 | 2022 |
| Monkeypox—Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era E Petersen, I Abubakar, C Ihekweazu, D Heymann, F Ntoumi, L Blumberg, ... International journal of infectious diseases 78, 78-84, 2019 | 201 | 2019 |
| Tuberculosis comorbidity with communicable and noncommunicable diseases M Bates, BJ Marais, A Zumla Cold Spring Harbor perspectives in medicine 5 (11), a017889, 2015 | 141 | 2015 |
| Towards host-directed therapies for tuberculosis A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ... Nature reviews Drug discovery 14 (8), 511-512, 2015 | 136 | 2015 |
| Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options A Zumla, ZA Memish, M Maeurer, M Bates, P Mwaba, JA Al-Tawfiq, ... The Lancet Infectious Diseases 14 (11), 1136-1149, 2014 | 135 | 2014 |
| New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis J O'Grady, M Maeurer, P Mwaba, N Kapata, M Bates, M Hoelscher, ... Current opinion in pulmonary medicine 17 (3), 134-141, 2011 | 135 | 2011 |
| Etiology, antibiotic resistance and risk factors for neonatal sepsis in a large referral center in Zambia M Kabwe, J Tembo, L Chilukutu, M Chilufya, F Ngulube, C Lukwesa, ... The Pediatric infectious disease journal 35 (7), e191-e198, 2016 | 128 | 2016 |
| Tuberculosis in prisons in sub-Saharan Africa–the need for improved health services, surveillance and control J O’Grady, M Hoelscher, R Atun, M Bates, P Mwaba, N Kapata, G Ferrara, ... Tuberculosis 91 (2), 173-178, 2011 | 127 | 2011 |
| Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines M Schito, GB Migliori, HA Fletcher, R McNerney, R Centis, L D'Ambrosio, ... Clinical infectious diseases 61 (suppl_3), S102-S118, 2015 | 125 | 2015 |